About

My career is centred at the intersection of quality enhancement, project management, clinical trials, and AI driven diagnostics. As Director of SZABMU’s Quality Enhancement Cell, I spearhead institutional performance evaluation, and accreditation initiatives while concurrently leading various translational research projects, including WHO COVID-19 cohorts and cancer immunotherapy trials. My research is focused on elucidating the mechanisms of metastasis, specifically investigating the SHH/GLI and Hippo pathways, alongside developing innovative diagnostic tools targeting p53 mutations and HER-2 over expression. These efforts have resulted in securing over PKR 200 million in research grants. I am dedicated to mentoring the next generation of scientists, having supervised over 20 undergraduate post graduate trainees, and I actively foster cross-disciplinary collaborations, with a notable emphasis on AI-based vascular disease management. My commitment to advancing precision medicine in resource-limited settings is reflected in my publications. Looking ahead, my primary goal is to scale AI-driven diagnostics to promote global health equity.

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications

Publications are unavailable.